Abstract bekijken

Deze abstract is toegekend aan sessie AOB Free Papers
Type presentatieOral presentation
TitelRuthenium Brachytherapy in eye tumors
DoelBetween 2019 and 2013, 214 applications with Ruthenium brachytherapy in Leuven University Hospital. This study audits the indications, results, and the rates of local and distal metastases.
MethodesRetrospective study
ResultatenOf 214 applications, 25 were conjunctival melanomas, 11 squamous cell carcinomas, 3 metastases, 2 hemangiomas, and 1 sacroma. The other 172 were uveal melanomas. Different sizes of plaques were used: 92 CCA, 91 CCB, 26 COB (for juxtapapillary tumors) and 5 CCC.
111 right eyes, and 100 males. Mean age at diagnosis was 66 years.
ConclusieRuthenium brachytherapy is a good and safe treatment for uveal and conjunctival melanomas, and can be very effective voor squamous cell carcinomas, large hemangiomas and metastases.
BelangenverstrengelingNee
Auteur 1
NaamMISSOTTEN
InitialenG
InstituutJessa Oogkliniek Hasselt and University Hospitals Leuven
StadHasselt/Leuven
Auteur 2
NaamVan Calster
InitialenJ
InstituutLeuven University Hospitals
StadLeuven
top ^